SEC Form 4 · accession 0001179110-17-006746
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael R Gallagher
Director
Period of report
May 3, 2017
Accepted (ET)
May 5, 2017 · 6:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1 | May 3, 2017 | F | 668 | $243.76 | D | 2,579 | D | |
| Ordinary Shares, par value $0.0001F1 | May 4, 2017 | M | 17,693 | $245.25 | A | 20,272 | D | |
| Ordinary Shares, par value $0.0001 | holding | — | — | — | 10,165 | I | Irrevocable Trust | |
| Ordinary Shares, par value $0.0001 | holding | — | — | — | 1,767 | I | Gallagher Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom Share UnitsF2 | $245.25 | May 4, 2017 | M | 17,693 | D | May 4, 2017 | May 4, 2017 | Ordinary Shares | 17,693 | 0 | D |
Explanation of responses
- F1Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
- F2Represents the disposition of Phantom Share Units acquired under the Allergan, Inc. Deferred Directors' Fee Program. Per the program terms, the Phantom Share Units were settled 100% in ordinary shares of the Issuer upon termination of the Reporting Person's service on the Issuer's board of directors on May 4, 2017.